Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K Fode
Two Randomised Phase II Trials of Subcutaneous Interleukin-2 and Histamine Dihydrochloride in Patients With Metastatic Renal Cell Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Related publications
A Randomised Dose Escalation Study of Subcutaneous Interleukin 2 With and Without Levamisole in Patients With Metastatic Renal Cell Carcinoma or Malignant Melanoma
British Journal of Cancer
Cancer Research
Oncology
Monocytes and Neutrophils as ‘Bad Guys’ for the Outcome of Interleukin-2 With and Without Histamine in Metastatic Renal Cell Carcinoma – Results From a Randomised Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
High-Dose Interleukin 2 in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid Features
PLoS ONE
Multidisciplinary
Perioperative Immunomodulation With Interleukin-2 in Patients With Renal Cell Carcinoma: Results of a Controlled Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
Intravenous Interleukin-2 in Patients Over 65 With Metastatic Renal Carcinoma
British Journal of Cancer
Cancer Research
Oncology
Durability of Responses in Patients With Metastatic Renal Cell Carcinoma Treated With High Dose Interleukin-2 (HD IL-2)
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
A Phase I/Ii Trial of BNC105P With Everolimus in Metastatic Renal Cell Carcinoma
Clinical Cancer Research
Cancer Research
Oncology
Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma
Urology
Urology
Recombinant Human Interleukin 6 in Metastatic Renal Cell Cancer: A Phase II Trial
British Journal of Cancer
Cancer Research
Oncology
